X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-03-16 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $64.85 | -1,700 | 112,904 | -1% | -$110,245 | ||||||
| D | 2026-03-17 | TNDM | Tandem Diabetes Care Inc | Novara Mark David | EVP, CHIEF COMMERCIAL OFFICER | S - Sale+OE | $23.05 | -187 | 37,656 | 0% | -$4,310 | |||||
| M | 2026-03-16 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $101.73 | -7,500 | 4,465,450 | 0% | -$762,971 | |||||
2026-03-17 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.16 | +531,000 | 7,516,404 | +8% | +$615,960 | ||||||
| D | 2026-03-13 | SI | Shoulder Innovations, Inc. | Points Jeffrey S. | CFO | P - Purchase | $15.00 | +2,000 | 70,835 | +3% | +$30,000 | |||||
2026-03-13 | SI | Shoulder Innovations, Inc. | Buchholz Richard | Dir | P - Purchase | $14.84 | +1,000 | 13,666 | +8% | +$14,840 | ||||||
2026-03-13 | SI | Shoulder Innovations, Inc. | Ball Robert Joseph | CEO, Exec COB | P - Purchase | $15.18 | +2,200 | 278,866 | +1% | +$33,392 | ||||||
2026-03-13 | ATEC | Alphatec Holdings, Inc. | Koning John Todd | CFO | S - Sale | $12.36 | -79,789 | 600,721 | -12% | -$986,192 | ||||||
2026-03-13 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $12.30 | -260,535 | 815,704 | -24% | -$3,204,581 | ||||||
2026-03-16 | IRTC | Irhythm Holdings, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $114.30 | -2,585 | 23,027 | -10% | -$295,466 | ||||||
2026-03-16 | KIDS | Orthopediatrics Corp | Hauser Joseph W | Pres Trauma, Def. Correction | S - Sale | $17.25 | -8,596 | 194,767 | -4% | -$148,281 | ||||||
2026-03-16 | KIDS | Orthopediatrics Corp | Hite Fred | COO, CFO | S - Sale | $17.25 | -12,993 | 277,477 | -4% | -$224,129 | ||||||
2026-03-16 | KIDS | Orthopediatrics Corp | Bailey David R | Pres, CEO | S - Sale | $17.25 | -19,535 | 298,020 | -6% | -$336,979 | ||||||
2026-03-16 | KIDS | Orthopediatrics Corp | Odle Gregory A | Pres of Scoliosis | S - Sale | $17.25 | -8,433 | 187,735 | -4% | -$145,469 | ||||||
2026-03-16 | KIDS | Orthopediatrics Corp | Gerritzen Daniel J | GC, Secretary | S - Sale | $17.25 | -8,614 | 149,533 | -5% | -$148,592 | ||||||
2026-03-13 | OSUR | Orasure Technologies Inc | McGrath Kenneth J | CFO | P - Purchase | $3.00 | +22,021 | 557,262 | +4% | +$66,030 | ||||||
2026-03-13 | OSUR | Orasure Technologies Inc | Eglinton Manner Carrie | Pres, CEO | P - Purchase | $3.00 | +22,022 | 2,158,574 | +1% | +$66,033 | ||||||
| M | 2025-12-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $30.27 | -2,917 | 136,216 | -2% | -$88,304 | |||||
2025-12-02 | BBNX | Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | S - Sale | $29.34 | -1,025 | 178,071 | -1% | -$30,069 | ||||||
2025-03-12 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $1.66 | -113,008 | 946,131 | -11% | -$187,277 | ||||||
2026-03-12 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $1.66 | -165,200 | 1,747,674 | -9% | -$273,769 | ||||||
2026-03-12 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $1.66 | -447,757 | 4,998,493 | -8% | -$742,023 | ||||||
2026-03-12 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $1.66 | -127,544 | 1,040,551 | -11% | -$211,366 | ||||||
2026-03-12 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.66 | -101,740 | 777,361 | -12% | -$168,604 | ||||||
2026-03-13 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $4.29 | +10,000 | 1,535,089 | +1% | +$42,900 | ||||||
| D | 2026-03-02 | CVRX | Cvrx, Inc. | Adamson Philip B. | Chief Medical Officer | S - Sale+OE | $7.90 | -1,262 | 61,578 | -2% | -$9,973 | |||||
| M | 2026-03-12 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.80 | -917 | 214,283 | 0% | -$734 | |||||
2026-03-12 | ATRC | Atricure, Inc. | Doraiswamy Vinayak | Chief Scientific Officer | S - Sale | $29.83 | -5,000 | 96,875 | -5% | -$149,150 | ||||||
2026-03-11 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $12.52 | -163,452 | 504,932 | -24% | -$2,046,419 | ||||||
2026-03-11 | BVS | Bioventus Inc. | McMurry-Heath Michelle | Dir | S - Sale | $8.79 | -12,000 | 44,997 | -21% | -$105,439 | ||||||
| D | 2026-03-13 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.00 | +1,250,000 | 10,178,196 | +14% | +$0 | |||||
2026-03-12 | SIBN | Si-Bone, Inc. | Nishimura Mika | Dir | S - Sale | $13.83 | -4,100 | 32,716 | -11% | -$56,700 | ||||||
| D | 2026-03-11 | LMAT | Lemaitre Vascular Inc | Kamke Trent G | Senior V. P., Operations | S - Sale+OE | $108.50 | -2,625 | 6,677 | -28% | -$284,813 | |||||
2026-03-11 | LMAT | Lemaitre Vascular Inc | Roberts David B | Pres, Dir | S - Sale | $107.68 | -3,312 | 14,667 | -18% | -$356,586 | ||||||
2026-03-12 | NVNO | Envveno Medical Corp | Duhay Francis | Dir | S - Sale | $11.52 | -140 | 2,502 | -5% | -$1,613 | ||||||
2026-03-10 | MDLN | Medline Inc. | Hellman & Friedman Capital Partners X (Parallel), L.P. | 10% | S - Sale | $40.51 | -26,131,237 | 86,473,497 | -23% | -$1,058,524,148 | ||||||
2026-03-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $22.66 | -12,837 | 581,450 | -2% | -$290,886 | ||||||
2026-03-10 | MDLN | Medline Inc. | Carlyle Mozart Coinvestment Holdings, L.P. | 10% | S - Sale | $41.00 | -26,105,840 | 125,454,241 | -17% | -$1,070,339,440 | ||||||
2026-03-10 | MDLN | Medline Inc. | Cp Circle Ml Holdco Gp, LLC | 10% | S - Sale | $41.00 | -26,105,840 | 125,454,241 | -17% | -$1,070,339,440 | ||||||
2026-03-10 | MDLN | Medline Inc. | Tc Group Cayman Investment Holdings, L.P. | 10% | S - Sale | $41.00 | -26,105,840 | 125,454,241 | -17% | -$1,070,339,440 | ||||||
2026-03-10 | MDLN | Medline Inc. | Bx Mozart Ml-2 Holdco L.P. | 10% | S - Sale | $40.51 | -27,852,986 | 2,428,681 | -92% | -$1,128,268,757 | ||||||
2026-03-10 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $25.65 | -3,243 | 111,021 | -3% | -$83,197 | ||||||
| M | 2026-03-10 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.80 | -13,720 | 215,200 | -6% | -$10,976 | |||||
| D | 2026-03-09 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $251.03 | -4,991 | 468,313 | -1% | -$1,252,902 | |||||
2026-03-10 | SOLV | Solventum Corp | Wendell Amy McBride | Dir | P - Purchase | $68.03 | +1,475 | 5,039 | +41% | +$100,344 | ||||||
2026-03-06 | SSII | Ss Innovations International, Inc. | Moll Frederic H | Dir, 10% | P - Purchase | $3.99 | +501,253 | 10,775,485 | +5% | +$1,999,999 | ||||||
2026-03-06 | SSII | Ss Innovations International, Inc. | Adams Timothy P. | Dir | P - Purchase | $3.99 | +300,000 | 5,331,902 | +6% | +$1,197,000 | ||||||
2026-03-06 | SSII | Ss Innovations International, Inc. | Sudhir Srivastava | COB, CEO, 10% | P - Purchase | $4.01 | +498,753 | 109,851,767 | 0% | +$2,000,000 | ||||||
| M | 2026-03-06 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $12.38 | -116,367 | 1,725,609 | -6% | -$1,441,041 | |||||
| M | 2026-03-09 | OFIX | Orthofix Medical Inc. | Capps Vickie L | Dir | P - Purchase | $12.46 | +5,000 | 27,585 | +22% | +$62,324 | |||||
| M | 2026-03-09 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $100.06 | -7,500 | 4,472,950 | 0% | -$750,475 | |||||
| M | 2026-02-25 | SINT | Sintx Technologies, Inc. | Lyons Christopher Michael | Dir | P - Purchase | $2.91 | +8,292 | 8,292 | New | +$24,092 | |||||
| AM | 2026-03-05 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.99 | -125,894 | 879,101 | -13% | -$250,932 | |||||
| M | 2026-03-05 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $2.04 | -83,021 | 1,168,095 | -7% | -$169,646 | |||||
| M | 2026-03-05 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.99 | -125,894 | 879,101 | -13% | -$250,938 | |||||
2026-03-06 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $2.01 | -30,845 | 1,059,139 | -3% | -$61,860 | ||||||
2026-03-06 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $2.01 | -34,094 | 1,912,874 | -2% | -$68,376 | ||||||
2026-03-06 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $2.01 | -78,187 | 5,446,250 | -1% | -$156,804 | ||||||
| M | 2026-03-05 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | P - Purchase | $24.59 | +426,262 | 475,777 | +861% | +$10,482,943 | |||||
| D | 2026-03-06 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale+OE | $23.70 | -6,892 | 114,264 | -6% | -$163,353 | |||||
| D | 2026-03-06 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale+OE | $23.70 | -6,721 | 152,264 | -4% | -$159,300 | |||||
2026-03-06 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $98.39 | -7,500 | 4,480,450 | 0% | -$737,919 | ||||||
2026-03-05 | TNDM | Tandem Diabetes Care Inc | Novara Mark David | EVP, CHIEF COMMERCIAL OFFICER | S - Sale | $22.81 | -2 | 35,969 | 0% | -$46 | ||||||
2026-03-05 | ATEC | Alphatec Holdings, Inc. | Marshall Tyson Eliot | GC, CORP. SEC. | S - Sale | $12.49 | -88,835 | 559,459 | -14% | -$1,109,549 | ||||||
2026-03-05 | HTFL | Heartflow, Inc. | Cullivan Julie A | Dir | S - Sale | $25.00 | -9,122 | 27,291 | -25% | -$228,050 | ||||||
2026-03-04 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, CLO, CS | S - Sale | $1.34 | -609 | 879,525 | 0% | -$816 | ||||||
2026-03-06 | DCTH | Delcath Systems, Inc. | Pennell Sandra | CFO | P - Purchase | $9.04 | +5,533 | 77,018 | +8% | +$50,018 | ||||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Andrews Julie | CFO | S - Sale | $12.74 | -4,788 | 88,746 | -5% | -$60,980 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Vitale Lucas | CP, BOO | S - Sale | $12.74 | -2,312 | 164,718 | -1% | -$29,445 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Calafiore Massimo | Pres, CEO | S - Sale | $12.74 | -12,220 | 320,136 | -4% | -$155,633 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Fisher Patrick | Pres, Global Limb Recon | S - Sale | $12.74 | -1,536 | 50,633 | -3% | -$19,562 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | McPherron Aviva | Pres, Global Ops, Qual | S - Sale | $12.74 | -2,559 | 67,853 | -4% | -$32,591 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Reinhardt Max | Pres, Global Spine | S - Sale | $12.74 | -2,133 | 25,348 | -8% | -$27,166 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Cedron Jorge Andres | CLO | S - Sale | $12.74 | -2,775 | 62,749 | -4% | -$35,342 | |||||
2026-03-04 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $11.57 | -353 | 139,133 | 0% | -$4,084 | ||||||
2026-03-04 | NVCR | Novocure Ltd | Leupin Nicolas | Former Chief Medical Officer | S - Sale | $13.31 | -1,100 | 102,979 | -1% | -$14,636 | ||||||
| D | 2026-03-04 | NVCR | Novocure Ltd | Weinberg Uri | Chf Medical, Innovation Ofr | S - Sale+OE | $13.31 | -6,412 | 267,190 | -2% | -$85,314 | |||||
| D | 2026-03-04 | NVCR | Novocure Ltd | Brackmann Christoph | CFO | S - Sale+OE | $13.31 | -6,412 | 182,842 | -3% | -$85,314 | |||||
| D | 2026-03-04 | NVCR | Novocure Ltd | Leonard Frank X | CEO | S - Sale+OE | $13.31 | -5,607 | 493,793 | -1% | -$74,603 | |||||
| DM | 2026-03-04 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale+OE | $13.72 | -48,623 | 72,832 | -40% | -$667,214 | |||||
| D | 2026-03-04 | NVCR | Novocure Ltd | Puri Michal Nath | CHRO | S - Sale+OE | $13.31 | -1,100 | 201,322 | -1% | -$14,636 | |||||
| D | 2026-03-03 | NVCR | Novocure Ltd | Doyle William F | Exec COB | S - Sale+OE | $12.98 | -71,887 | 328,397 | -18% | -$932,883 | |||||
2026-03-04 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $260.22 | -2,000 | 62,773 | -3% | -$520,440 | ||||||
2026-03-02 | PEN | Penumbra Inc | Yuen Maggie | CFO | S - Sale | $342.30 | -2,432 | 18,353 | -12% | -$832,474 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Radhakrishnan Srikanth | Chief Science,Techn. Officer | S - Sale | $1.43 | -10,483 | 345,736 | -3% | -$14,991 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $1.43 | -67,813 | 2,152,509 | -3% | -$96,973 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $1.43 | -7,732 | 465,734 | -2% | -$11,057 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $1.43 | -12,237 | 390,755 | -3% | -$17,499 | ||||||
2026-03-03 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $37.78 | -901 | 139,088 | -1% | -$34,036 | ||||||
| M | 2026-03-03 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $37.93 | -12,805 | 185,095 | -6% | -$485,728 | |||||
2026-03-03 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $37.78 | -2,149 | 60,097 | -3% | -$81,180 | ||||||
2026-03-03 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $37.78 | -4,573 | 230,794 | -2% | -$172,748 | ||||||
2026-03-03 | AORT | Artivion, Inc. | Berry Lance A | EVP, COO, CFO, Treasurer | S - Sale | $37.78 | -6,316 | 210,827 | -3% | -$238,591 | ||||||
2026-03-03 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $37.78 | -17,887 | 947,275 | -2% | -$675,692 | ||||||
2025-12-15 | NPCE | Neuropace Inc | Morrell Martha | CHIEF MEDICAL OFFICER | S - Sale | $15.97 | -25,000 | 48,624 | -34% | -$399,250 | ||||||
| D | 2026-03-02 | CARL | Carlsmed, Inc. | Cordonnier Michael | CEO, Pres | S - Sale+OE | $13.29 | -197,855 | 1,550,477 | -11% | -$2,629,889 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale+OE | $12.36 | -834 | 139,486 | -1% | -$10,310 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | S - Sale+OE | $12.36 | -1,026 | 179,096 | -1% | -$12,683 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale+OE | $12.36 | -1,064 | 188,793 | -1% | -$13,153 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $12.36 | -1,428 | 172,729 | -1% | -$17,652 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |